Pmv Pharmaceuticals, INC Form 4 insider transactions
NASDAQ
Director Carol Gallagher reported the acquisition and subsequent gifting of stock options in PMV Pharmaceuticals.
NASDAQ
Director Kirsten Flowers of PMV Pharmaceuticals reports the acquisition of stock options.
NASDAQ
Director Charles M. Baum reports the acquisition of stock options in PMV Pharmaceuticals, Inc.